Cargando…
A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology
Chronic kidney disease (CKD) patients and more so CKD patients treated with renin–angiotensin–aldosterone system inhibitors (RAASi) are prone to experience hyperkalaemia, a condition associated with an increased risk of death. This represents a true dilemma in daily practice since RAASi are the corn...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392417/ https://www.ncbi.nlm.nih.gov/pubmed/30837805 http://dx.doi.org/10.1093/eurheartj/suy032 |